Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab (Q34664457)

3 August 2017

title

Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab (English)

1 reference

3 August 2017

0 references

1 reference

Elizabeth McElnea

1

1 reference

3 August 2017

Aine Ní Mhéalóid

2

1 reference

3 August 2017

Sarah Moran

3

1 reference

3 August 2017

Rory Kelly

4

1 reference

3 August 2017

Tim Fulcher

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

10 September 2014

1 reference

3 August 2017

1 reference

3 August 2017

volume

33

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

424-427

1 reference

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Orbital myositis associated with ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

21 January 2018

Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

CTLA-4 and its role in autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

Drug-Induced Graves Disease From CTLA-4 Receptor Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01676830.2014.949792

10.3109/01676830.2014.949792

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference